Altamira Therapeutics Ltd. buy melinda
Start price
22.10.18
/
50%
€18.40
Target price
30.10.19
€26.16
Performance (%)
-92.34%
End price
30.10.19
€1.41
Summary
This prediction ended on 30.10.19 with a price of €1.41. The BUY prediction by melinda for Altamira Therapeutics Ltd. performed very badly with a performance of -92.34%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altamira Therapeutics Ltd. | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Altamira Therapeutics Ltd. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 26/11 Publication de résultats
Develops biotherapies for inner ear disorders
Auris Medical Holding AG engages in the provision of biopharmaceutical business.
It focuses on the development of novel products for the treatment of inner ear disorders.
It includes tinnitus, haring loss, and meniere's disease.
The company was founded by Thomas Meyer in April 2003 and is headquartered in Zug, Switzerland.
Auris Medical Holding AG engages in the provision of biopharmaceutical business.
It focuses on the development of novel products for the treatment of inner ear disorders.
It includes tinnitus, haring loss, and meniere's disease.
The company was founded by Thomas Meyer in April 2003 and is headquartered in Zug, Switzerland.
Nombre d'employés : 24 personnes.
Stopped prediction by melinda for Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€0.39
25.10.22
25.10.22
€0.60
25.10.23
25.10.23
0.00%
26.10.23
26.10.23
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€0.65
22.10.22
22.10.22
€1.50
22.10.23
22.10.23
-40.17%
25.10.22
25.10.22
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€0.58
17.03.20
17.03.20
€1.30
04.11.21
04.11.21
141.38%
05.11.21
05.11.21
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€6.04
05.02.18
05.02.18
€11.18
14.03.18
14.03.18
389.70%
14.03.18
14.03.18
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€12.00
26.08.17
26.08.17
€27.06
13.11.17
13.11.17
11.28%
13.11.17
13.11.17
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€40.39
19.08.16
19.08.16
€67.65
20.02.17
20.02.17
-58.60%
20.02.17
20.02.17
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€78.83
19.04.16
19.04.16
€108.24
18.08.16
18.08.16
-49.66%
18.08.16
18.08.16